Neurocrine Biosciences
NBIX
#1201
Rank
S$21.03 B
Marketcap
$207.78
Share price
-0.96%
Change (1 day)
9.06%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company